[
  {
    "title": "艾德生物(300685.SZ)：厦门屹祥完成减持1.69%股份",
    "href": "http://stock.jrj.com.cn/2023/01/04162737258520.shtml",
    "datetime": "2023-01-04 16:27:16",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)截至12月底已累计回购353.1226万股",
    "href": "http://stock.jrj.com.cn/2023/01/03215637256783.shtml",
    "datetime": "2023-01-03 21:56:03",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：厦门屹祥减持数过半 已减持1%股份",
    "href": "http://stock.jrj.com.cn/2022/12/23185737235019.shtml",
    "datetime": "2022-12-23 18:57:30",
    "code": "300685"
  },
  {
    "title": "A股异动 | 艾德生物跌4% 股东拟减持不超667.56万股",
    "href": "http://stock.jrj.com.cn/2022/12/07140637194632.shtml",
    "datetime": "2022-12-07 14:06:50",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：厦门屹祥拟减持不超667.56万股",
    "href": "http://stock.jrj.com.cn/2022/12/06164137192203.shtml",
    "datetime": "2022-12-06 16:41:49",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：截至11月底累计耗资9997.01万元回购0.89%股份",
    "href": "http://stock.jrj.com.cn/2022/12/01171737181859.shtml",
    "datetime": "2022-12-01 17:17:48",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)截至10月底已累计回购0.81%的股份",
    "href": "http://stock.jrj.com.cn/2022/11/01200037104500.shtml",
    "datetime": "2022-11-01 20:00:08",
    "code": "300685"
  },
  {
    "title": "艾德生物2022年前三季度净利2.24亿同比增长26.96% 到期理财产品收益增加",
    "href": "http://stock.jrj.com.cn/2022/10/24225037079931.shtml",
    "datetime": "2022-10-24 22:50:45",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)第三季度净利润1.35亿元、同比增长106.75%",
    "href": "http://stock.jrj.com.cn/2022/10/24171937078378.shtml",
    "datetime": "2022-10-24 17:19:22",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)与百济神州达成靶向药物临床研究合作",
    "href": "http://stock.jrj.com.cn/2022/10/11165537047327.shtml",
    "datetime": "2022-10-11 16:55:44",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：截至8月底已累计回购122.624万股",
    "href": "http://stock.jrj.com.cn/2022/09/01202336964176.shtml",
    "datetime": "2022-09-01 20:23:20",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)截至7月底已累计回购69.48万股",
    "href": "http://stock.jrj.com.cn/2022/08/02173436863342.shtml",
    "datetime": "2022-08-02 17:34:44",
    "code": "300685"
  },
  {
    "title": "A股异动 | 艾德生物放量跌超7% Q2净利同比大减47% 疫情冲击明显",
    "href": "http://stock.jrj.com.cn/2022/08/01140836858817.shtml",
    "datetime": "2022-08-01 14:08:57",
    "code": "300685"
  },
  {
    "title": "艾德生物2022年上半年净利8928.78万同比下滑19.79% 医疗机构肿瘤患者就诊受限",
    "href": "http://stock.jrj.com.cn/2022/07/29231136855763.shtml",
    "datetime": "2022-07-29 23:11:29",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：上半年净利降19.79%至8928.78万元",
    "href": "http://stock.jrj.com.cn/2022/07/29174236854455.shtml",
    "datetime": "2022-07-29 17:42:02",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)截至6月底已累计回购69.48万股",
    "href": "http://stock.jrj.com.cn/2022/07/04211336781314.shtml",
    "datetime": "2022-07-04 21:13:02",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：子公司取得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/06/17160736738047.shtml",
    "datetime": "2022-06-17 16:07:27",
    "code": "300685"
  },
  {
    "title": "股价腰斩，IVD龙头摊牌：我不装了，实在带不动“猪队友”",
    "href": "http://stock.jrj.com.cn/2022/06/06174836706279.shtml",
    "datetime": "2022-06-06 17:48:20",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：拟转让SDC2产品权益及子公司艾之维股权",
    "href": "http://stock.jrj.com.cn/2022/06/05145636703469.shtml",
    "datetime": "2022-06-05 14:56:18",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：截至5月底已累计回购69.48万股",
    "href": "http://stock.jrj.com.cn/2022/06/02161036700551.shtml",
    "datetime": "2022-06-02 16:10:18",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：2021年度权益分派10转8派2.3元 股权登记日为5月30日",
    "href": "http://stock.jrj.com.cn/2022/05/24211536675559.shtml",
    "datetime": "2022-05-24 21:15:19",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：120.42万股限制性股票5月16日解锁上市",
    "href": "http://stock.jrj.com.cn/2022/05/11185336635505.shtml",
    "datetime": "2022-05-11 18:53:36",
    "code": "300685"
  },
  {
    "title": "艾德生物：49.01万股限制性股票将于5月10日上市流通",
    "href": "http://stock.jrj.com.cn/2022/05/07141436588419.shtml",
    "datetime": "2022-05-07 14:14:15",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：49.01万股限制性股票将于5月10日上市流通",
    "href": "http://stock.jrj.com.cn/2022/05/05204436572008.shtml",
    "datetime": "2022-05-05 20:44:01",
    "code": "300685"
  },
  {
    "title": "艾德生物2022年第一季度净利5361.48万同比增长23.46% 投资收益同比增长",
    "href": "http://stock.jrj.com.cn/2022/04/21111236416959.shtml",
    "datetime": "2022-04-21 11:12:58",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：一季度净利增23.46%至5361.48万元",
    "href": "http://stock.jrj.com.cn/2022/04/20174236410861.shtml",
    "datetime": "2022-04-20 17:42:53",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：与阿斯利康达成靶向药物临床研究合作",
    "href": "http://stock.jrj.com.cn/2022/04/18164936385155.shtml",
    "datetime": "2022-04-18 16:49:26",
    "code": "300685"
  },
  {
    "title": "艾德生物2021年净利2.4亿同比增长32.86% 董事长LI-MOU ZHENG薪酬96.63万",
    "href": "http://stock.jrj.com.cn/2022/04/12051536311633.shtml",
    "datetime": "2022-04-12 05:15:09",
    "code": "300685"
  },
  {
    "title": "艾德生物2021年净利同比增32.86% 拟10转8派2.3",
    "href": "http://stock.jrj.com.cn/2022/04/11221736309306.shtml",
    "datetime": "2022-04-11 22:17:36",
    "code": "300685"
  },
  {
    "title": "艾德生物2021年营收和净利润实现中高增长：研发强度得到再加强 销售费用达33%",
    "href": "http://stock.jrj.com.cn/2022/04/11193436306635.shtml",
    "datetime": "2022-04-11 19:34:08",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)2021年度净利润升32.86%至2.4亿元 拟10转8派2.3元",
    "href": "http://stock.jrj.com.cn/2022/04/11184236306114.shtml",
    "datetime": "2022-04-11 18:42:14",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：截至3月底已累计回购28.34万股",
    "href": "http://stock.jrj.com.cn/2022/04/01164836247564.shtml",
    "datetime": "2022-04-01 16:48:41",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：获得PD-L1抗体试剂(免疫组织化学法)的医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/03/11193034815282.shtml",
    "datetime": "2022-03-11 19:30:15",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：取得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/03/11161834813952.shtml",
    "datetime": "2022-03-11 16:18:16",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：3月9日首次回购28.34万股",
    "href": "http://stock.jrj.com.cn/2022/03/10154834808734.shtml",
    "datetime": "2022-03-10 15:48:20",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：尚未实施股份回购",
    "href": "http://stock.jrj.com.cn/2022/03/03175634516671.shtml",
    "datetime": "2022-03-03 17:56:13",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)业绩快报：2021年归母净利增28.35%至2.31亿元",
    "href": "http://stock.jrj.com.cn/2022/02/28195834501669.shtml",
    "datetime": "2022-02-28 19:58:40",
    "code": "300685"
  },
  {
    "title": "A股异动 | 艾德生物涨5% 拟以1亿元至2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2022/02/15104634352704.shtml",
    "datetime": "2022-02-15 10:46:58",
    "code": "300685"
  },
  {
    "title": "A股异动 | 艾德生物(300685.SZ)反弹近4% 拟以1亿-2亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/02/15093534352307.shtml",
    "datetime": "2022-02-15 09:35:46",
    "code": "300685"
  },
  {
    "title": "艾德生物将花不超2亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2022/02/14183234345618.shtml",
    "datetime": "2022-02-14 18:32:05",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：拟以1亿-2亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/02/14164234344867.shtml",
    "datetime": "2022-02-14 16:42:10",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：收到医疗器械变更注册文件",
    "href": "http://stock.jrj.com.cn/2022/01/27164934230779.shtml",
    "datetime": "2022-01-27 16:49:59",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：肺癌多基因联合检测产品PCR-11基因进入日本医保",
    "href": "http://stock.jrj.com.cn/2022/01/07163434133743.shtml",
    "datetime": "2022-01-07 16:34:15",
    "code": "300685"
  },
  {
    "title": "艾德生物：公司产品进入日本医保",
    "href": "http://stock.jrj.com.cn/2022/01/07163234133731.shtml",
    "datetime": "2022-01-07 16:32:45",
    "code": "300685"
  },
  {
    "title": "艾德生物股东厦门科英减持75万股 套现5433.75万 第三季度公司净利6523.35万",
    "href": "http://stock.jrj.com.cn/2021/12/21215034043473.shtml",
    "datetime": "2021-12-21 21:50:45",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：股东厦门科英完成减持75万股",
    "href": "http://stock.jrj.com.cn/2021/12/21172634042197.shtml",
    "datetime": "2021-12-21 17:26:43",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：持股6.56%股东厦门科英拟减持不超0.34%股份",
    "href": "http://stock.jrj.com.cn/2021/12/15174734020158.shtml",
    "datetime": "2021-12-15 17:47:35",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：取得一项日本特许厅颁发的发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/11/08222633824749.shtml",
    "datetime": "2021-11-08 22:26:15",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：第三季度净利升43.92%至6523.35万元",
    "href": "http://stock.jrj.com.cn/2021/10/25182333748666.shtml",
    "datetime": "2021-10-25 18:23:47",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：获得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/08/06211733214668.shtml",
    "datetime": "2021-08-06 21:17:07",
    "code": "300685"
  },
  {
    "title": "艾德生物：上半年利润增逾三成 重要股东频繁减持",
    "href": "http://stock.jrj.com.cn/2021/08/05085833205335.shtml",
    "datetime": "2021-08-05 08:58:50",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)上半年净利润1.11亿元 同比增长37.77%",
    "href": "http://stock.jrj.com.cn/2021/07/25162133145047.shtml",
    "datetime": "2021-07-25 16:21:05",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：取得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/07/21184333130929.shtml",
    "datetime": "2021-07-21 18:43:07",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：PCR-11基因伴随诊断试剂在日获批",
    "href": "http://stock.jrj.com.cn/2021/06/29122333015171.shtml",
    "datetime": "2021-06-29 12:23:08",
    "code": "300685"
  },
  {
    "title": "艾德生物股东龙岩鑫莲鑫减持80.07万股 套现7215.05万",
    "href": "http://stock.jrj.com.cn/2021/06/21210732971620.shtml",
    "datetime": "2021-06-21 21:07:33",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：龙岩鑫莲鑫已完成减持80.0694万股",
    "href": "http://stock.jrj.com.cn/2021/06/21173432970340.shtml",
    "datetime": "2021-06-21 17:34:21",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：2020年度拟10派2.5元 6月8日股权登记",
    "href": "http://stock.jrj.com.cn/2021/06/02221732865748.shtml",
    "datetime": "2021-06-02 22:17:27",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：全资子公司取得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/06/02165832863723.shtml",
    "datetime": "2021-06-02 16:58:09",
    "code": "300685"
  },
  {
    "title": "艾德生物：部分限制性股票回购注销完成",
    "href": "http://stock.jrj.com.cn/2021/06/01170632857941.shtml",
    "datetime": "2021-06-01 17:06:54",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：133.02万股限制性股票将解除限售上市流通",
    "href": "http://stock.jrj.com.cn/2021/05/14200732757064.shtml",
    "datetime": "2021-05-14 20:07:35",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：收到日本特许厅颁发的一项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/05/11155932735701.shtml",
    "datetime": "2021-05-11 15:59:31",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：57.975万股限制性股票将解除限售上市流通",
    "href": "http://stock.jrj.com.cn/2021/05/10213332731902.shtml",
    "datetime": "2021-05-10 21:33:30",
    "code": "300685"
  },
  {
    "title": "艾德生物2021年第一季度净利增长67.59% 产品销售增加",
    "href": "http://stock.jrj.com.cn/2021/04/20230332412506.shtml",
    "datetime": "2021-04-20 23:03:59",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)一季度净利润升67.59%至4342.78万元",
    "href": "http://stock.jrj.com.cn/2021/04/20170632410501.shtml",
    "datetime": "2021-04-20 17:06:02",
    "code": "300685"
  },
  {
    "title": "艾德生物：目前公司PD-L1抗体试剂（免疫组织化学法）已处于注册报批中",
    "href": "http://stock.jrj.com.cn/2021/04/19171132402758.shtml",
    "datetime": "2021-04-19 17:11:55",
    "code": "300685"
  },
  {
    "title": "艾德生物：公司提供全流程专业合规的产品",
    "href": "http://stock.jrj.com.cn/2021/04/19165532402648.shtml",
    "datetime": "2021-04-19 16:55:45",
    "code": "300685"
  },
  {
    "title": "艾德生物：公司的目标是向肿瘤患者提供适应临床检测需求的、合规的、高品质的产品和服务",
    "href": "http://stock.jrj.com.cn/2021/04/19164732402583.shtml",
    "datetime": "2021-04-19 16:47:27",
    "code": "300685"
  },
  {
    "title": "艾德生物2020年净利1.8亿同比增长33.11% 董事长LI-MOUZHENG薪酬96.09万",
    "href": "http://stock.jrj.com.cn/2021/04/13134732364245.shtml",
    "datetime": "2021-04-13 13:47:41",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)2020年度净利润升33.11%至1.8亿元 拟10派2.5元",
    "href": "http://stock.jrj.com.cn/2021/04/12215332359935.shtml",
    "datetime": "2021-04-12 21:53:38",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：与海和药物达成靶向药物临床研究合作",
    "href": "http://stock.jrj.com.cn/2021/03/12172132116265.shtml",
    "datetime": "2021-03-12 17:21:15",
    "code": "300685"
  },
  {
    "title": "艾德生物：公司SDC2肠癌甲基化产品已经获得国家药监局（NMPA）批准上市",
    "href": "http://stock.jrj.com.cn/2021/02/26154632033015.shtml",
    "datetime": "2021-02-26 15:46:57",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)取得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/02/22183332007259.shtml",
    "datetime": "2021-02-22 18:33:56",
    "code": "300685"
  },
  {
    "title": "艾德生物：国内首家专业肿瘤医疗企业 年初肠癌早筛试剂盒获批",
    "href": "http://stock.jrj.com.cn/2021/02/20130931997287.shtml",
    "datetime": "2021-02-20 13:09:19",
    "code": "300685"
  },
  {
    "title": "艾德生物2020年度净利1.79亿增长32.47% 各项经营工作有序开展",
    "href": "http://stock.jrj.com.cn/2021/02/18200331988224.shtml",
    "datetime": "2021-02-18 20:03:49",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)业绩快报：2020年净利升32.47%至1.79亿元",
    "href": "http://stock.jrj.com.cn/2021/02/18163531986958.shtml",
    "datetime": "2021-02-18 16:35:35",
    "code": "300685"
  },
  {
    "title": "[艾德生物]强强再联合,艾德生物与阿斯利康签署卵巢癌HRD伴随诊断战略合作",
    "href": "http://stock.jrj.com.cn/2021/01/30000031828784.shtml",
    "datetime": "2021-01-30 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：厦门屹祥拟以大宗交易减持不超1.33%的股份",
    "href": "http://stock.jrj.com.cn/2021/01/20195631731080.shtml",
    "datetime": "2021-01-20 19:56:14",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：厦门屹祥已完成减持1.23%的股份",
    "href": "http://stock.jrj.com.cn/2021/01/20195431731076.shtml",
    "datetime": "2021-01-20 19:54:31",
    "code": "300685"
  },
  {
    "title": "艾德生物：公司人类SDC2基因甲基化产品已于2021年获批",
    "href": "http://stock.jrj.com.cn/2021/01/15180031700257.shtml",
    "datetime": "2021-01-15 18:00:24",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：公司一个第三类体外诊断试剂获医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/01/13155031684102.shtml",
    "datetime": "2021-01-13 15:50:46",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：龙岩鑫莲鑫已减持71.064万股",
    "href": "http://stock.jrj.com.cn/2021/01/12180131677508.shtml",
    "datetime": "2021-01-12 18:01:06",
    "code": "300685"
  },
  {
    "title": "艾德生物股东龙柏宏信减持58.14万股 套现约4701.43万元",
    "href": "http://stock.jrj.com.cn/2020/12/31195531614327.shtml",
    "datetime": "2020-12-31 19:55:09",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：龙柏宏信减持股份计划已完成 累计减持58.14万股",
    "href": "http://stock.jrj.com.cn/2020/12/31180831613575.shtml",
    "datetime": "2020-12-31 18:08:54",
    "code": "300685"
  },
  {
    "title": "广生堂(300436.SZ)与艾德生物签订分子检测与伴随诊断战略合作框架协议及相关附属协议",
    "href": "http://stock.jrj.com.cn/2020/12/25212531572581.shtml",
    "datetime": "2020-12-25 21:25:20",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)与广生堂达成靶向药物临床研究合作",
    "href": "http://stock.jrj.com.cn/2020/12/25210431572519.shtml",
    "datetime": "2020-12-25 21:04:48",
    "code": "300685"
  },
  {
    "title": "[广生堂]广生堂与艾德生物达成伴随诊断战略合作",
    "href": "http://stock.jrj.com.cn/2020/12/25000031583353.shtml",
    "datetime": "2020-12-25 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物股东减持213.55万股 套现约1.65亿元",
    "href": "http://stock.jrj.com.cn/2020/12/23193431555491.shtml",
    "datetime": "2020-12-23 19:34:54",
    "code": "300685"
  },
  {
    "title": "午间公告集锦：艾德生物与默克达成靶向药物临床研究合作",
    "href": "http://stock.jrj.com.cn/2020/12/23122331553220.shtml",
    "datetime": "2020-12-23 12:23:46",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：PCR-11基因将用于默克MET抑制剂Tepotinib在中国的伴随诊断",
    "href": "http://stock.jrj.com.cn/2020/12/23115431553117.shtml",
    "datetime": "2020-12-23 11:54:35",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：控股股东减持1%股份 减持计划已完成",
    "href": "http://stock.jrj.com.cn/2020/12/11180331465841.shtml",
    "datetime": "2020-12-11 18:03:50",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：控股股东拟大宗交易减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2020/12/07210031433287.shtml",
    "datetime": "2020-12-07 21:00:25",
    "code": "300685"
  },
  {
    "title": "[艾德生物]喜讯频传:艾德生物再获两项国家级认定",
    "href": "http://stock.jrj.com.cn/2020/12/04000031428840.shtml",
    "datetime": "2020-12-04 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：持股5%以上股东厦门屹祥拟减持不超1.23%公司股份",
    "href": "http://stock.jrj.com.cn/2020/11/25194031347710.shtml",
    "datetime": "2020-11-25 19:40:55",
    "code": "300685"
  },
  {
    "title": "[艾德生物]进博会快讯 | 艾德生物与阿斯利康签署国际合作",
    "href": "http://stock.jrj.com.cn/2020/11/06000031232136.shtml",
    "datetime": "2020-11-06 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物股东厦门科英减持443.88万股 套现约3.44亿元",
    "href": "http://stock.jrj.com.cn/2020/11/04192131215813.shtml",
    "datetime": "2020-11-04 19:21:09",
    "code": "300685"
  },
  {
    "title": "艾德生物：公司及全资子公司今年累计收到政府补助逾2800万元",
    "href": "http://stock.jrj.com.cn/2020/11/02174031201706.shtml",
    "datetime": "2020-11-02 17:40:47",
    "code": "300685"
  },
  {
    "title": "艾德生物(300685.SZ)：累计收到各类政府补助资金约2811.49万元",
    "href": "http://stock.jrj.com.cn/2020/11/02171231201591.shtml",
    "datetime": "2020-11-02 17:12:34",
    "code": "300685"
  },
  {
    "title": "艾德生物2020年前三季度净利1.26亿增长15.87% 提坏账准备减少",
    "href": "http://stock.jrj.com.cn/2020/10/20215331094706.shtml",
    "datetime": "2020-10-20 21:53:20",
    "code": "300685"
  },
  {
    "title": "艾德生物股东龙岩鑫莲鑫减持251.28万股 套现约1.97亿元",
    "href": "http://stock.jrj.com.cn/2020/09/29193730861098.shtml",
    "datetime": "2020-09-29 19:37:28",
    "code": "300685"
  },
  {
    "title": "艾德生物股东OrbiMed Asia减持360万股 套现约2.93亿元",
    "href": "http://stock.jrj.com.cn/2020/09/08222030706369.shtml",
    "datetime": "2020-09-08 22:20:41",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物携手海和生物助力国产创新靶向药进军日本市场",
    "href": "http://stock.jrj.com.cn/2020/08/26000030604749.shtml",
    "datetime": "2020-08-26 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物与德国默克达成靶向药物临床研究合作",
    "href": "http://stock.jrj.com.cn/2020/08/10202930467854.shtml",
    "datetime": "2020-08-10 20:29:56",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物与德国默克达成日本市场的伴随诊断战略合作",
    "href": "http://stock.jrj.com.cn/2020/08/10000030604750.shtml",
    "datetime": "2020-08-10 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物2020年上半年净利8080.46万增长3.38% 加强市场推广",
    "href": "http://stock.jrj.com.cn/2020/07/27225130357680.shtml",
    "datetime": "2020-07-27 22:51:27",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物发明专利斩获“中国专利奖银奖”",
    "href": "http://stock.jrj.com.cn/2020/07/17000030604747.shtml",
    "datetime": "2020-07-17 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物获中国专利银奖",
    "href": "http://stock.jrj.com.cn/2020/07/16210730264125.shtml",
    "datetime": "2020-07-16 21:07:32",
    "code": "300685"
  },
  {
    "title": "快讯：艾德生物急速拉升6.82% 主力资金净流入2297.01万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/29132030085923.shtml",
    "datetime": "2020-06-29 13:20:12",
    "code": "300685"
  },
  {
    "title": "快讯：艾德生物急速拉升6.82% 主力资金净流入1921.92万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/29132030085899.shtml",
    "datetime": "2020-06-29 13:20:02",
    "code": "300685"
  },
  {
    "title": "艾德生物与阿斯利康达成市场推广合作",
    "href": "http://stock.jrj.com.cn/2020/06/22201129990597.shtml",
    "datetime": "2020-06-22 20:11:09",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物&阿斯利康强强联合,共创肺癌诊疗合作新模式",
    "href": "http://stock.jrj.com.cn/2020/06/22000030604748.shtml",
    "datetime": "2020-06-22 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物与安进达成靶向药物临床研究合作",
    "href": "http://stock.jrj.com.cn/2020/05/22175429741541.shtml",
    "datetime": "2020-05-22 17:54:28",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物与安进达成伴随诊断战略合作",
    "href": "http://stock.jrj.com.cn/2020/05/22000030604745.shtml",
    "datetime": "2020-05-22 00:00:00",
    "code": "300685"
  },
  {
    "title": "受股权激励费用摊销拖累 艾德生物一季度净利下滑20.48%",
    "href": "http://stock.jrj.com.cn/2020/04/21225529341629.shtml",
    "datetime": "2020-04-21 22:55:50",
    "code": "300685"
  },
  {
    "title": "尴尬了！艾德生物业务招待费增3倍而业绩增速却大幅回落",
    "href": "http://stock.jrj.com.cn/2020/04/14085529281221.shtml",
    "datetime": "2020-04-14 08:55:00",
    "code": "300685"
  },
  {
    "title": "艾德生物2019年度净利同比增6.89% 拟10转5派2.5元",
    "href": "http://stock.jrj.com.cn/2020/04/13214229277211.shtml",
    "datetime": "2020-04-13 21:42:02",
    "code": "300685"
  },
  {
    "title": "艾德生物：2019年净利润同比增长6.89% 拟10转5派2.5元",
    "href": "http://stock.jrj.com.cn/2020/04/13201729276751.shtml",
    "datetime": "2020-04-13 20:17:08",
    "code": "300685"
  },
  {
    "title": "艾德生物：2019年净利同比增6.89% 拟10转5派2.5元",
    "href": "http://stock.jrj.com.cn/2020/04/13200629276708.shtml",
    "datetime": "2020-04-13 20:06:00",
    "code": "300685"
  },
  {
    "title": "艾德生物2020年一季度预计净利2509万元–2704万元 同比下降17.02%-23%",
    "href": "http://stock.jrj.com.cn/2020/04/09230029250053.shtml",
    "datetime": "2020-04-09 23:00:04",
    "code": "300685"
  },
  {
    "title": "艾德生物股东龙岩鑫莲鑫减持210万股 套现约1.53亿元",
    "href": "http://stock.jrj.com.cn/2020/03/24213529097289.shtml",
    "datetime": "2020-03-24 21:35:41",
    "code": "300685"
  },
  {
    "title": "艾德生物：与强生中国签署合作协议 将成其肿瘤产品线伴随诊断合作伙伴",
    "href": "http://stock.jrj.com.cn/2020/03/24164129095122.shtml",
    "datetime": "2020-03-24 16:41:24",
    "code": "300685"
  },
  {
    "title": "艾德生物：与强生达成靶向药物临床研究合作",
    "href": "http://stock.jrj.com.cn/2020/03/24160029094894.shtml",
    "datetime": "2020-03-24 16:00:20",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物与强生达成伴随诊断战略合作",
    "href": "http://stock.jrj.com.cn/2020/03/24000030237276.shtml",
    "datetime": "2020-03-24 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：孙公司取得执业许可证 可开展医疗检测业务",
    "href": "http://stock.jrj.com.cn/2020/03/11165129001793.shtml",
    "datetime": "2020-03-11 16:51:42",
    "code": "300685"
  },
  {
    "title": "艾德生物：全资孙公司取得执业许可证 可开展医疗检测业务",
    "href": "http://stock.jrj.com.cn/2020/03/11164829001813.shtml",
    "datetime": "2020-03-11 16:48:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]快讯:艾德生物再添一家临检中心",
    "href": "http://stock.jrj.com.cn/2020/03/11000030237277.shtml",
    "datetime": "2020-03-11 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物股东OrbiMed Asia减持267万股 套现约1.99亿元",
    "href": "http://stock.jrj.com.cn/2020/03/03183128945989.shtml",
    "datetime": "2020-03-03 18:31:42",
    "code": "300685"
  },
  {
    "title": "艾德生物2019年度盈利1.35亿增长7% 主营业务稳定增长",
    "href": "http://stock.jrj.com.cn/2020/02/26181728898381.shtml",
    "datetime": "2020-02-26 18:17:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东龙柏宏信拟清仓减持1.43%股份",
    "href": "http://stock.jrj.com.cn/2020/02/24204728884541.shtml",
    "datetime": "2020-02-24 20:47:26",
    "code": "300685"
  },
  {
    "title": "艾德生物使用部分闲置募集资金1亿元进行现金管理",
    "href": "http://stock.jrj.com.cn/2020/02/14220928831685.shtml",
    "datetime": "2020-02-14 22:09:43",
    "code": "300685"
  },
  {
    "title": "艾德生物：首批1.5万人份新型冠状病毒检测试剂盒正式打包装箱",
    "href": "http://stock.jrj.com.cn/2020/02/04205228768638.shtml",
    "datetime": "2020-02-04 20:52:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/19223028702609.shtml",
    "datetime": "2020-01-19 22:30:00",
    "code": "300685"
  },
  {
    "title": "艾德生物2019年度预计净利1.27亿元–1.39亿元 同比增长0%-10%",
    "href": "http://stock.jrj.com.cn/2020/01/19183928701999.shtml",
    "datetime": "2020-01-19 18:39:36",
    "code": "300685"
  },
  {
    "title": "[艾德生物]喜讯频传:艾德生物喜获“国家企业技术中心”认定及“国家科学技术进步奖二等奖”",
    "href": "http://stock.jrj.com.cn/2020/01/14000030237278.shtml",
    "datetime": "2020-01-14 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物近日获得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2020/01/03200028626171.shtml",
    "datetime": "2020-01-03 20:00:01",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物2019年大事记",
    "href": "http://stock.jrj.com.cn/2019/12/31000030237281.shtml",
    "datetime": "2019-12-31 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物与阿斯利康达成市场推广合作",
    "href": "http://stock.jrj.com.cn/2019/12/18221728552874.shtml",
    "datetime": "2019-12-18 22:17:55",
    "code": "300685"
  },
  {
    "title": "艾德生物：与阿斯利康达成市场推广合作",
    "href": "http://stock.jrj.com.cn/2019/12/18154628551556.shtml",
    "datetime": "2019-12-18 15:46:31",
    "code": "300685"
  },
  {
    "title": "艾德生物：与日本卫材公司达成靶向药物临床研究合作",
    "href": "http://stock.jrj.com.cn/2019/11/22154328438301.shtml",
    "datetime": "2019-11-22 15:43:54",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物与日本卫材签订全球诊断合作协议",
    "href": "http://stock.jrj.com.cn/2019/11/22000030237279.shtml",
    "datetime": "2019-11-22 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德分子检测产品被写入ESMO最新NTRK基因检测共识",
    "href": "http://stock.jrj.com.cn/2019/10/23000030237283.shtml",
    "datetime": "2019-10-23 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物2019年前三季度净利约1.07亿元–1.09亿元 推进新产品上市",
    "href": "http://stock.jrj.com.cn/2019/10/13204028239298.shtml",
    "datetime": "2019-10-13 20:40:51",
    "code": "300685"
  },
  {
    "title": "艾德生物：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/13193028239115.shtml",
    "datetime": "2019-10-13 19:30:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：前三季度净利预增32％-33％",
    "href": "http://stock.jrj.com.cn/2019/10/13181128238988.shtml",
    "datetime": "2019-10-13 18:11:25",
    "code": "300685"
  },
  {
    "title": "艾德生物：前三季度净利预增逾3成",
    "href": "http://stock.jrj.com.cn/2019/10/13180028238981.shtml",
    "datetime": "2019-10-13 18:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物国际化的又一里程碑:艾惠健(海外版)入选日本国家癌症中心项目(LC-SCRUM Asia)",
    "href": "http://stock.jrj.com.cn/2019/09/30000030237284.shtml",
    "datetime": "2019-09-30 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东龙岩鑫莲鑫减持期限届满 拟继续减持不超1.9%",
    "href": "http://stock.jrj.com.cn/2019/09/19204628155410.shtml",
    "datetime": "2019-09-19 20:46:13",
    "code": "300685"
  },
  {
    "title": "艾德生物：龙岩鑫莲鑫减持期限届满 拟继续减持",
    "href": "http://stock.jrj.com.cn/2019/09/19190028155130.shtml",
    "datetime": "2019-09-19 19:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物股东拟减持不超3.5%股份",
    "href": "http://stock.jrj.com.cn/2019/08/29212628057886.shtml",
    "datetime": "2019-08-29 21:26:12",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东拟减持不超3.5%股份",
    "href": "http://stock.jrj.com.cn/2019/08/29201128057541.shtml",
    "datetime": "2019-08-29 20:11:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东龙柏宏信减持1.86%股份 拟继续减持不超2%",
    "href": "http://stock.jrj.com.cn/2019/08/16211627989651.shtml",
    "datetime": "2019-08-16 21:16:49",
    "code": "300685"
  },
  {
    "title": "艾德生物：厦门龙柏宏信减持1.86%股份 拟继续减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2019/08/16204427989541.shtml",
    "datetime": "2019-08-16 20:44:21",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东厦门龙柏宏信减持1.86%股份",
    "href": "http://stock.jrj.com.cn/2019/08/16203127989527.shtml",
    "datetime": "2019-08-16 20:31:09",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东厦门龙柏宏信减持1.86%股份 拟继续减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2019/08/16202027989466.shtml",
    "datetime": "2019-08-16 20:20:00",
    "code": "300685"
  },
  {
    "title": "艾德生物2019年上半年实现净利7816万 产品销售增加",
    "href": "http://stock.jrj.com.cn/2019/07/30094227902490.shtml",
    "datetime": "2019-07-30 09:42:42",
    "code": "300685"
  },
  {
    "title": "艾德生物：上半年净利7816万元 同比增12%",
    "href": "http://stock.jrj.com.cn/2019/07/29192127900427.shtml",
    "datetime": "2019-07-29 19:21:00",
    "code": "300685"
  },
  {
    "title": "艾德生物2019年上半年盈利7500万元–7900万元 同比增长7.79%-13.54%",
    "href": "http://stock.jrj.com.cn/2019/07/15120527841197.shtml",
    "datetime": "2019-07-15 12:05:59",
    "code": "300685"
  },
  {
    "title": "艾德生物：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/14215027838575.shtml",
    "datetime": "2019-07-14 21:50:01",
    "code": "300685"
  },
  {
    "title": "艾德生物研发开花结果 靶向药物临床研究再某新突破",
    "href": "http://stock.jrj.com.cn/2019/06/24090227750084.shtml",
    "datetime": "2019-06-24 09:02:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：与礼来制药子公司达成靶向药物临床研究合作",
    "href": "http://stock.jrj.com.cn/2019/06/23171927743997.shtml",
    "datetime": "2019-06-23 17:19:02",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物携手LOXO ONCOLOGY(礼来制药)推进LOXO-292国际临床研究",
    "href": "http://stock.jrj.com.cn/2019/06/23000030237286.shtml",
    "datetime": "2019-06-23 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]喜讯频传!艾德生物ROS1、EGFR检测产品分别纳入韩国、中国台湾医保!",
    "href": "http://stock.jrj.com.cn/2019/06/13000030237290.shtml",
    "datetime": "2019-06-13 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物股东厦门龙柏宏信减持143万股 套现约7373万元",
    "href": "http://stock.jrj.com.cn/2019/05/20221327597345.shtml",
    "datetime": "2019-05-20 22:13:15",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东OrbiMed Asia已累计减持1.46%股份",
    "href": "http://stock.jrj.com.cn/2019/05/17164927586810.shtml",
    "datetime": "2019-05-17 16:49:48",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东OrbiMed Asia已减持1.46%股份",
    "href": "http://stock.jrj.com.cn/2019/05/17160027586574.shtml",
    "datetime": "2019-05-17 16:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]BRCA基因NGS检测,从规范化开始",
    "href": "http://stock.jrj.com.cn/2019/04/09000030237287.shtml",
    "datetime": "2019-04-09 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物去年净利1.27亿元 同比增长35% 董事长年薪96万元",
    "href": "http://stock.jrj.com.cn/2019/03/27073827247450.shtml",
    "datetime": "2019-03-27 07:38:40",
    "code": "300685"
  },
  {
    "title": "艾德生物：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/03/25224027232757.shtml",
    "datetime": "2019-03-25 22:40:01",
    "code": "300685"
  },
  {
    "title": "艾德生物：一季度净利预增20%-40%",
    "href": "http://stock.jrj.com.cn/2019/03/25210427232060.shtml",
    "datetime": "2019-03-25 21:04:05",
    "code": "300685"
  },
  {
    "title": "艾德生物：2018年净利同比增35% 拟10派1.8元",
    "href": "http://stock.jrj.com.cn/2019/03/25210327232056.shtml",
    "datetime": "2019-03-25 21:03:02",
    "code": "300685"
  },
  {
    "title": "艾德生物：体外诊断试剂获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2019/02/27181027098108.shtml",
    "datetime": "2019-02-27 18:10:32",
    "code": "300685"
  },
  {
    "title": "艾德生物：获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2019/02/27174927098054.shtml",
    "datetime": "2019-02-27 17:49:00",
    "code": "300685"
  },
  {
    "title": "艾德生物2018年利润1.3亿增长35% 抓住肿瘤精准医疗市场契机",
    "href": "http://stock.jrj.com.cn/2019/02/27095127095930.shtml",
    "datetime": "2019-02-27 09:51:15",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物BRCA NGS检测产品(维汝健)正式获批上市",
    "href": "http://stock.jrj.com.cn/2019/02/27000030237274.shtml",
    "datetime": "2019-02-27 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物股东龙岩鑫莲鑫减持405万股 套现约2.34亿元",
    "href": "http://stock.jrj.com.cn/2019/02/26071927089987.shtml",
    "datetime": "2019-02-26 07:19:52",
    "code": "300685"
  },
  {
    "title": "艾德生物股东厦门龙柏宏信累计减持62万股 套现约2781万元",
    "href": "http://stock.jrj.com.cn/2019/02/14222527045230.shtml",
    "datetime": "2019-02-14 22:25:21",
    "code": "300685"
  },
  {
    "title": "艾德生物股东OrbiMedAsia累计减持144万股 套现约6000万",
    "href": "http://stock.jrj.com.cn/2019/02/14222427045227.shtml",
    "datetime": "2019-02-14 22:24:09",
    "code": "300685"
  },
  {
    "title": "艾德生物：拟推406万股限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/12080027032679.shtml",
    "datetime": "2019-02-12 08:00:02",
    "code": "300685"
  },
  {
    "title": "艾德生物：推406万股限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2019/02/11204727029449.shtml",
    "datetime": "2019-02-11 20:47:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物与香港善觅合作,为港澳患者提供多基因检测服务",
    "href": "http://stock.jrj.com.cn/2019/01/30000030237272.shtml",
    "datetime": "2019-01-30 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物高研发投入布局潜力赛道 大小非减持打压估值",
    "href": "http://stock.jrj.com.cn/2019/01/24083626950025.shtml",
    "datetime": "2019-01-24 08:36:30",
    "code": "300685"
  },
  {
    "title": "艾德生物：2018年净利预增32.89%-38.2%",
    "href": "http://stock.jrj.com.cn/2019/01/08201126874849.shtml",
    "datetime": "2019-01-08 20:11:37",
    "code": "300685"
  },
  {
    "title": "艾德生物：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/08201026874834.shtml",
    "datetime": "2019-01-08 20:10:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]喜讯!艾德生物ROS1试剂盒中国台湾获批!",
    "href": "http://stock.jrj.com.cn/2018/12/19000030237280.shtml",
    "datetime": "2018-12-19 00:00:00",
    "code": "300685"
  },
  {
    "title": "午间公告集锦：艾德生物获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2018/11/20115825378771.shtml",
    "datetime": "2018-11-20 11:58:44",
    "code": "300685"
  },
  {
    "title": "午间公告：艾德生物获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2018/11/20115325378764.shtml",
    "datetime": "2018-11-20 11:53:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物重磅NGS产品(维惠健)获批上市",
    "href": "http://stock.jrj.com.cn/2018/11/20000025379419.shtml",
    "datetime": "2018-11-20 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物2018年国际经销商年会在沪成功举办",
    "href": "http://stock.jrj.com.cn/2018/11/14000025343580.shtml",
    "datetime": "2018-11-14 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物2018年国际经销商年会在沪成功举办",
    "href": "http://stock.jrj.com.cn/2018/11/14000030237271.shtml",
    "datetime": "2018-11-14 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物两股东拟合计减持不超3.2%股份",
    "href": "http://stock.jrj.com.cn/2018/11/08205625320213.shtml",
    "datetime": "2018-11-08 20:56:46",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东拟减持不超2.2%股份",
    "href": "http://stock.jrj.com.cn/2018/11/08195725320071.shtml",
    "datetime": "2018-11-08 19:57:00",
    "code": "300685"
  },
  {
    "title": "艾德生物违规接受样本受罚",
    "href": "http://stock.jrj.com.cn/2018/10/30024225274516.shtml",
    "datetime": "2018-10-30 02:42:08",
    "code": "300685"
  },
  {
    "title": "[艾德生物]NSCLC全程化管理高峰论坛暨艾德生物肺癌多基因检测产品上市发布会隆重举行",
    "href": "http://stock.jrj.com.cn/2018/10/29000030237270.shtml",
    "datetime": "2018-10-29 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]NSCLC全程化管理高峰论坛暨艾德生物肺癌多基因检测产品上市发布会隆重举行",
    "href": "http://stock.jrj.com.cn/2018/10/29000025278096.shtml",
    "datetime": "2018-10-29 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：受到科技部行政处罚不会对公司生产经营产生重大影响",
    "href": "http://stock.jrj.com.cn/2018/10/26221625266213.shtml",
    "datetime": "2018-10-26 22:16:55",
    "code": "300685"
  },
  {
    "title": "艾德生物：科技部处罚不会对公司生产经营产生重大影响",
    "href": "http://stock.jrj.com.cn/2018/10/26215625266137.shtml",
    "datetime": "2018-10-26 21:56:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：科技部的行政处罚不会对公司产生重大影响",
    "href": "http://stock.jrj.com.cn/2018/10/26205725265934.shtml",
    "datetime": "2018-10-26 20:57:53",
    "code": "300685"
  },
  {
    "title": "[艾德生物]C位出道!中国精准医疗领域标杆企业艾德生物亮相朝闻天下!",
    "href": "http://stock.jrj.com.cn/2018/10/23000030237269.shtml",
    "datetime": "2018-10-23 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]C位出道!中国精准医疗领域标杆企业艾德生物亮相朝闻天下!",
    "href": "http://stock.jrj.com.cn/2018/10/23000025245876.shtml",
    "datetime": "2018-10-23 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/15083025202473.shtml",
    "datetime": "2018-10-15 08:30:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]国际市场再下一城:艾德ROS1试剂盒在韩国获批伴随诊断试剂",
    "href": "http://stock.jrj.com.cn/2018/10/11000025184976.shtml",
    "datetime": "2018-10-11 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]国际市场再下一城:艾德ROS1试剂盒在韩国获批伴随诊断试剂",
    "href": "http://stock.jrj.com.cn/2018/10/11000030237266.shtml",
    "datetime": "2018-10-11 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物:研发、渠道和商业模式构建高护城河",
    "href": "http://stock.jrj.com.cn/2018/09/28101125148238.shtml",
    "datetime": "2018-09-28 10:11:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：带量采购政策对公司无重大影响",
    "href": "http://stock.jrj.com.cn/2018/09/21120025124116.shtml",
    "datetime": "2018-09-21 12:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]喜讯!艾德医学检验所全技术平台通过美国CAP认证!",
    "href": "http://stock.jrj.com.cn/2018/09/21000030237265.shtml",
    "datetime": "2018-09-21 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]喜讯!艾德医学检验所全技术平台通过美国CAP认证!",
    "href": "http://stock.jrj.com.cn/2018/09/21000025149415.shtml",
    "datetime": "2018-09-21 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]肺癌一线检测新产品——艾德生物肺癌多基因联合检测产品“艾惠健”获批",
    "href": "http://stock.jrj.com.cn/2018/08/24000025003082.shtml",
    "datetime": "2018-08-24 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]肺癌一线检测新产品——艾德生物肺癌多基因联合检测产品“艾惠健”获批",
    "href": "http://stock.jrj.com.cn/2018/08/24000030237264.shtml",
    "datetime": "2018-08-24 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东龙岩鑫莲鑫减持公司1.22%股份",
    "href": "http://stock.jrj.com.cn/2018/08/22164424986664.shtml",
    "datetime": "2018-08-22 16:44:53",
    "code": "300685"
  },
  {
    "title": "艾德生物遇技术更迭挑战 被疑难续高增长",
    "href": "http://stock.jrj.com.cn/2018/08/14013424946912.shtml",
    "datetime": "2018-08-14 01:34:23",
    "code": "300685"
  },
  {
    "title": "艾德生物股东龙岩鑫莲鑫拟减持不超5.47%股份",
    "href": "http://stock.jrj.com.cn/2018/08/02183024896795.shtml",
    "datetime": "2018-08-02 18:30:50",
    "code": "300685"
  },
  {
    "title": "艾德生物：股东拟减持不超5.47%股份",
    "href": "http://stock.jrj.com.cn/2018/08/02183024896790.shtml",
    "datetime": "2018-08-02 18:30:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：平稳高速增长持续 新品种催化值得关注",
    "href": "http://stock.jrj.com.cn/2018/07/30104524878059.shtml",
    "datetime": "2018-07-30 10:45:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：上半年净利6958万元 同比增58%",
    "href": "http://stock.jrj.com.cn/2018/07/27200024873354.shtml",
    "datetime": "2018-07-27 20:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：2018年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/07/27195024873293.shtml",
    "datetime": "2018-07-27 19:50:00",
    "code": "300685"
  },
  {
    "title": "艾德生物上半年净利润同比增长58%",
    "href": "http://stock.jrj.com.cn/2018/07/27194624873299.shtml",
    "datetime": "2018-07-27 19:46:52",
    "code": "300685"
  },
  {
    "title": "艾德生物：受益靶向药放量 中报业绩超预期",
    "href": "http://stock.jrj.com.cn/2018/07/16093424819185.shtml",
    "datetime": "2018-07-16 09:34:00",
    "code": "300685"
  },
  {
    "title": "艾德生物年报推10转8派2.4元 股权登记6月27日",
    "href": "http://stock.jrj.com.cn/2018/06/19183524698166.shtml",
    "datetime": "2018-06-19 18:35:19",
    "code": "300685"
  },
  {
    "title": "艾德生物：基于NGS技术平台的检测试剂正在审批中",
    "href": "http://stock.jrj.com.cn/2018/06/04131424633890.shtml",
    "datetime": "2018-06-04 13:14:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]恪守规范,精益求精!",
    "href": "http://stock.jrj.com.cn/2018/05/25000024602689.shtml",
    "datetime": "2018-05-25 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]恪守规范,精益求精!",
    "href": "http://stock.jrj.com.cn/2018/05/25000030237262.shtml",
    "datetime": "2018-05-25 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物拟800万美元参股投资UST公司",
    "href": "http://stock.jrj.com.cn/2018/05/23174024580396.shtml",
    "datetime": "2018-05-23 17:40:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]喜讯!艾德生物子公司-上海厦维中心实验室通过美国CAP认证!",
    "href": "http://stock.jrj.com.cn/2018/05/22000024602692.shtml",
    "datetime": "2018-05-22 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]喜讯!艾德生物子公司-上海厦维中心实验室通过美国CAP认证!",
    "href": "http://stock.jrj.com.cn/2018/05/22000030237263.shtml",
    "datetime": "2018-05-22 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：治疗癌症药物进口零关税对公司无重大影响",
    "href": "http://stock.jrj.com.cn/2018/04/29181024472264.shtml",
    "datetime": "2018-04-29 18:10:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：一季度净利预增33%-51%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/04/03084224342752.shtml",
    "datetime": "2018-04-03 08:42:21",
    "code": "300685"
  },
  {
    "title": "艾德生物：年报净利同比增4成 拟10转8派2.4元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/04/03084224342726.shtml",
    "datetime": "2018-04-03 08:42:21",
    "code": "300685"
  },
  {
    "title": "艾德生物：2017年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2018/04/02204024340685.shtml",
    "datetime": "2018-04-02 20:40:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：2017年净利同比增4成 拟10转8派2.4元",
    "href": "http://stock.jrj.com.cn/2018/04/02182524339970.shtml",
    "datetime": "2018-04-02 18:25:00",
    "code": "300685"
  },
  {
    "title": "艾德生物：2018年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/02175024339658.shtml",
    "datetime": "2018-04-02 17:50:00",
    "code": "300685"
  },
  {
    "title": "艾德生物年报拟10转8派2.4元",
    "href": "http://stock.jrj.com.cn/2018/04/02174324339608.shtml",
    "datetime": "2018-04-02 17:43:36",
    "code": "300685"
  },
  {
    "title": "[艾德生物]中国肿瘤界再传捷报!",
    "href": "http://stock.jrj.com.cn/2018/03/30000024337577.shtml",
    "datetime": "2018-03-30 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]中国肿瘤界再传捷报!",
    "href": "http://stock.jrj.com.cn/2018/03/30000030237259.shtml",
    "datetime": "2018-03-30 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]液体活检里程碑式突破!以伴随诊断试剂标准审评的ctDNA检测试剂盒获批",
    "href": "http://stock.jrj.com.cn/2018/01/19000030237257.shtml",
    "datetime": "2018-01-19 00:00:00",
    "code": "300685"
  },
  {
    "title": "艾德生物 肿瘤个体化诊断迎来黄金时代 公司望成为最大受益者 强烈推荐评级",
    "href": "http://stock.jrj.com.cn/2018/01/17105423959893.shtml",
    "datetime": "2018-01-17 10:54:00",
    "code": "300685"
  },
  {
    "title": "艾德生物产品研发项目获得政府补助1150万元",
    "href": "http://stock.jrj.com.cn/2017/11/26182123696896.shtml",
    "datetime": "2017-11-26 18:21:00",
    "code": "300685"
  },
  {
    "title": "艾德生物收到政府补助690万元",
    "href": "http://stock.jrj.com.cn/2017/11/26181023696885.shtml",
    "datetime": "2017-11-26 18:10:03",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物获批牵头建设厦门市基因检测技术应用示范中心",
    "href": "http://stock.jrj.com.cn/2017/11/23000023838398.shtml",
    "datetime": "2017-11-23 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物携重磅创新产品亮相第18届世界肺癌大会,获得广泛关注",
    "href": "http://stock.jrj.com.cn/2017/10/20000023838400.shtml",
    "datetime": "2017-10-20 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]上海厦维生物技术有限公司开业庆典",
    "href": "http://stock.jrj.com.cn/2017/10/18000023838401.shtml",
    "datetime": "2017-10-18 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物股份登陆创业板,着力肿瘤靶向用药分子诊断市场,启明创投等支持",
    "href": "http://stock.jrj.com.cn/2017/08/02000023838392.shtml",
    "datetime": "2017-08-02 00:00:00",
    "code": "300685"
  },
  {
    "title": "弘宇股份、艾德生物网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/26083422798286.shtml",
    "datetime": "2017-07-26 08:34:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物参加2017欧洲肺癌大会ELCC 2017",
    "href": "http://stock.jrj.com.cn/2017/05/09000023838394.shtml",
    "datetime": "2017-05-09 00:00:00",
    "code": "300685"
  },
  {
    "title": "[艾德生物]艾德生物HER2突变试剂盒助力阿法替尼II期临床研究",
    "href": "http://stock.jrj.com.cn/2017/02/07000023838391.shtml",
    "datetime": "2017-02-07 00:00:00",
    "code": "300685"
  }
]